Therapeutic Area | MeSH |
---|---|
hemic and lymphatic diseases | D006425 |
nutritional and metabolic diseases | D009750 |
Brand Name | Status | Last Update |
---|---|---|
enbrace hr | unapproved drug other | 2025-01-02 |
enlyte | unapproved drug other | 2022-07-01 |
leucovorin | ANDA | 2014-09-26 |
leucovorin calcium | ANDA | 2025-09-29 |
paxlyte | unapproved drug other | 2024-12-19 |
pyrimethamine leucovorin | unapproved drug other | 2015-11-30 |
Indication | Ontology | MeSH | ICD-10 |
---|---|---|---|
folic acid deficiency | EFO_0001070 | D005494 | E53.8 |
megaloblastic anemia | — | D000749 | D53.1 |
Indication | MeSH | Ontology | ICD-10 | Ph 1 | Ph 2 | Ph 3 | Ph 4 | Other | Total |
---|---|---|---|---|---|---|---|---|---|
Colorectal neoplasms | D015179 | — | — | 144 | 423 | 207 | 12 | 35 | 745 |
Pancreatic neoplasms | D010190 | EFO_0003860 | C25 | 95 | 190 | 43 | 1 | 19 | 300 |
Neoplasms | D009369 | — | C80 | 135 | 112 | 48 | 2 | 9 | 276 |
Rectal neoplasms | D012004 | — | — | 50 | 156 | 66 | 1 | 14 | 267 |
Colonic neoplasms | D003110 | — | C18 | 53 | 104 | 72 | 1 | 15 | 217 |
Stomach neoplasms | D013274 | EFO_0003897 | C16 | 33 | 137 | 41 | 2 | 15 | 208 |
Adenocarcinoma | D000230 | — | — | 46 | 142 | 32 | 1 | 10 | 205 |
Neoplasm metastasis | D009362 | EFO_0009708 | — | 38 | 84 | 31 | 1 | 6 | 149 |
Liver neoplasms | D008113 | EFO_1001513 | C22.0 | 12 | 59 | 31 | 1 | 19 | 115 |
Lymphoma | D008223 | — | C85.9 | 18 | 49 | 18 | 1 | 7 | 83 |
Indication | MeSH | Ontology | ICD-10 | Ph 1 | Ph 2 | Ph 3 | Ph 4 | Other | Total |
---|---|---|---|---|---|---|---|---|---|
Carcinoma | D002277 | — | C80.0 | 19 | 70 | 33 | — | 11 | 122 |
Hepatocellular carcinoma | D006528 | — | C22.0 | 10 | 63 | 29 | — | 18 | 114 |
Precursor cell lymphoblastic leukemia-lymphoma | D054198 | — | C91.0 | 19 | 44 | 27 | — | 5 | 85 |
Leukemia | D007938 | — | C95 | 11 | 40 | 24 | — | 4 | 72 |
Ovarian neoplasms | D010051 | EFO_0003893 | C56 | 38 | 30 | 6 | — | 4 | 67 |
Pancreatic ductal carcinoma | D021441 | — | — | 24 | 33 | 6 | — | 2 | 59 |
Gastrointestinal neoplasms | D005770 | — | C26.9 | 20 | 23 | 8 | — | 3 | 43 |
Recurrence | D012008 | — | — | 18 | 18 | 6 | — | 4 | 40 |
Biliary tract neoplasms | D001661 | — | C24.9 | 8 | 34 | 4 | — | 3 | 40 |
Breast neoplasms | D001943 | EFO_0003869 | C50 | 17 | 20 | 3 | — | 3 | 39 |
Indication | MeSH | Ontology | ICD-10 | Ph 1 | Ph 2 | Ph 3 | Ph 4 | Other | Total |
---|---|---|---|---|---|---|---|---|---|
Healthy volunteers/patients | — | — | — | 9 | 2 | — | — | 15 | 26 |
Endometrial neoplasms | D016889 | EFO_0004230 | — | 12 | 11 | — | — | — | 16 |
Myeloid leukemia acute | D015470 | — | C92.0 | 13 | 4 | — | — | — | 15 |
Triple negative breast neoplasms | D064726 | — | — | 11 | 8 | — | — | — | 15 |
Cognitive dysfunction | D060825 | — | G31.84 | 1 | 3 | — | — | 10 | 14 |
Squamous cell carcinoma of head and neck | D000077195 | — | — | 6 | 9 | — | — | — | 12 |
Mantle-cell lymphoma | D020522 | — | C83.1 | 4 | 7 | — | — | — | 11 |
Appendiceal neoplasms | D001063 | EFO_0003880 | C18.1 | 6 | 4 | — | — | 1 | 11 |
Aging | D000375 | GO_0007568 | R41.81 | — | 2 | — | — | 9 | 11 |
Hodgkin disease | D006689 | — | C81 | 7 | 5 | — | — | — | 10 |
Indication | MeSH | Ontology | ICD-10 | Ph 1 | Ph 2 | Ph 3 | Ph 4 | Other | Total |
---|---|---|---|---|---|---|---|---|---|
Pharmacokinetics | D010599 | — | — | 5 | — | — | — | 1 | 6 |
Gastrointestinal stromal tumors | D046152 | EFO_0000505 | C49.A | 5 | — | — | — | — | 5 |
T-cell lymphoma cutaneous | D016410 | — | C84.A | 3 | — | — | — | 2 | 5 |
Sezary syndrome | D012751 | — | C84.1 | 3 | — | — | — | 1 | 4 |
Chronic obstructive pulmonary disease | D029424 | EFO_0000341 | J44.9 | 2 | — | — | — | 1 | 3 |
Skin neoplasms | D012878 | EFO_0004198 | C44 | 1 | — | — | — | 1 | 2 |
Necrosis | D009336 | — | — | 1 | — | — | — | 1 | 2 |
Pseudomyxoma peritonei | D011553 | EFO_0007456 | — | 1 | — | — | — | 1 | 2 |
Drug interactions | D004347 | — | — | 2 | — | — | — | — | 2 |
Therapeutic equivalency | D013810 | — | — | 2 | — | — | — | — | 2 |
Indication | MeSH | Ontology | ICD-10 | Ph 1 | Ph 2 | Ph 3 | Ph 4 | Other | Total |
---|---|---|---|---|---|---|---|---|---|
Gyrate atrophy | D015799 | — | — | — | — | — | — | 12 | 12 |
Breast feeding | D001942 | — | — | — | — | — | — | 8 | 8 |
Avitaminosis | D001361 | EFO_0005878 | E56.9 | — | — | — | — | 7 | 7 |
Alopecia | D000505 | — | L64 | — | — | — | — | 5 | 5 |
Healthy diet | D000072001 | — | — | — | — | — | — | 5 | 5 |
Feeding behavior | D005247 | — | — | — | — | — | — | 5 | 5 |
Diet therapy | D004035 | — | — | — | — | — | — | 4 | 4 |
Child development | D002657 | — | — | — | — | — | — | 4 | 4 |
Nutritional status | D009752 | — | — | — | — | — | — | 4 | 4 |
Postoperative cognitive complications | D000079690 | — | — | — | — | — | — | 4 | 4 |
Drug common name | Leucovorin |
INN | calcium folinate |
Description | Folinic acid, also known as leucovorin, is a medication used to decrease the toxic effects of methotrexate and pyrimethamine. It is also used in combination with 5-fluorouracil to treat colorectal cancer and pancreatic cancer, may be used to treat folate deficiency that results in anemia, and methanol poisoning. It is taken by mouth, injection into a muscle, or injection into a vein.
|
Classification | Small molecule |
Drug class | — |
Image (chem structure or protein) | ![]() |
Structure (InChI/SMILES or Protein Sequence) | Nc1nc(=O)c2c([nH]1)NCC(CNc1ccc(C(=O)N[C@@H](CCC(=O)O)C(=O)O)cc1)N2C=O |
PDB | — |
CAS-ID | 58-05-9 |
RxCUI | — |
ChEMBL ID | CHEMBL1679 |
ChEBI ID | 15640 |
PubChem CID | 6006 |
DrugBank | DB03256 |
UNII ID | RPR1R4C0P4 (ChemIDplus, GSRS) |